153 results on '"Cho, Min Soon"'
Search Results
2. Role of circulating mitochondria in venous thrombosis in glioblastoma
3. Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer
4. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.
5. The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer
6. Role of tissue-factor bearing extracellular vesicles released from ovarian cancer cells in platelet aggregation in vitro and venous thrombosis in mice
7. Podoplanin and microthrombi in lung injury
8. The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis
9. The effect of ADAMTS13 on graft‐versus‐host disease.
10. Role of ADP receptors on platelets in the growth of ovarian cancer
11. Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
12. The impact of the complement receptors C3aR1 and C5aR1 on the progression of melanoma
13. Abstract 5406: A deep learning enabled digital pathology platform for characterization of cancer-associated thrombosis of ovarian cancer
14. Supplementary Data from Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response
15. Supplementary Table 3 from Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response
16. Supplemental Table 1 from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
17. Supplemental Table 2 from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
18. Data from Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response
19. An integrated supplementary document for 3 figures from Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
20. Supplemental Methods from Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
21. Erythropoietin Stimulates Tumor Growth via EphB4
22. Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes
23. Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
24. Autocrine Effects of Tumor-Derived Complement
25. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
26. Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8
27. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
28. Platelets Increase the Expression of PD-L1 in Ovarian Cancer
29. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles
30. TAp63 Prevents Premature Aging by Promoting Adult Stem Cell Maintenance
31. Allelic Frequencies of Six (CA)n Microsatellite Markers of the Dystrophin Gene in the Korean Population
32. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
33. Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf
34. Disruption of the dynamic sub-cellular localization of the Xenopus tumorhead protein causes embryonic lethality at the early gastrula transition
35. Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response
36. The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis
37. Inhibiting DDX3X Triggers Tumor-Intrinsic Type I Interferon Response and Enhances Anti-Tumor Immunity
38. The Inhibition of Platelets Restore Anti-Tumor Immune Response to Ovarian Cancer and Its Therapeutic Implication
39. Platelets Promote Activation of the Complement System in Ovarian Cancer
40. Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression
41. Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer
42. A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets
43. Abstract 5048: Platelet FAK is a critical regulator of tumor growth after withdrawal of anti-angiogenic therapy
44. Platelets increase the proliferation of ovarian cancer cells
45. Author Correction: TAp63suppresses metastasis through coordinate regulation of Dicerand miRNAs
46. Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial–Mesenchymal Transition
47. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A
48. Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer
49. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
50. Complement Component 3 (C3) Is a Mediator of Epithelial-Mesenchymal Transition (EMT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.